Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GlaxoSmithKline Grows Theravance Stake: Investing in the Pipeline
Seeking Alpha
Saturday, December 4, 2010 - 11:57am
tags:
GSK, Theravance
Medicis Suit Claims Aurobindo Infringes U.S. Patents for Solodyn Acne Drug
Bloomberg
Saturday, December 4, 2010 - 11:55am
tags:
Medicis, Aurobindo, Solodyn, acne, lawsuits
Pfizer Properly Warned About Prempro Health Risks, Jury Finds
Bloomberg
Friday, December 3, 2010 - 11:31am
tags:
Wyeth, Pfizer, Prempro, HRT
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ Online
Friday, December 3, 2010 - 11:06am
tags:
FDA, obesity, Contrave, hypertension, Orexigen
Cyclacel rallies on drug update
Marketwatch
Friday, December 3, 2010 - 11:04am
tags:
Cyclacel, Sapacitabine, MDS
Insurers Force How Much Generic Switching?
Pharmalot
Friday, December 3, 2010 - 11:01am
tags:
insurance, generics, generic switching
Gilead Sciences: Nice Cash Flow, But What’s in the Pipe?
Seeking Alpha
Friday, December 3, 2010 - 10:59am
tags:
Gilead Sciences, pipelines
200 Day Level, Key For Sanofi-Aventis
Traders Huddle
Friday, December 3, 2010 - 9:31am
tags:
Sanofi
Orexigen's Diet Pill Has Unclear Benefits, an FDA Staff Review Indicates
Bloomberg
Friday, December 3, 2010 - 8:46am
tags:
Orexigen, FDA, Contrave, obesity
Pharma Mergers Scrutinized In Insider Trading Probe
Reuters
Friday, December 3, 2010 - 8:24am
tags:
M&A, insider trading, MedImmune, AstraZeneca, Wyeth, Pfizer, Merck, Schering Plough
Zogenix IPO: Invest in Curing Migranes
Seeking Alpha
Friday, December 3, 2010 - 8:22am
tags:
migraines, Zogenix, IPOs
Orexigen: Don't Count Contrave Out Yet
Seeking Alpha
Friday, December 3, 2010 - 6:45am
tags:
FDA, obesity, Orexigen, Contrave, Arena Pharmaceuticals, Vivus
Alnylam says it won Europe RNA patent dispute
Yahoo/AP
Friday, December 3, 2010 - 6:44am
tags:
patents, Alnylam, RNA, gene silencing, Merck, Pfizer, Sima
AstraZeneca: FDA panel says vandetanib could help some medullary thyroid cancer patients
Yahoo/AP
Thursday, December 2, 2010 - 6:59pm
tags:
FDA, AstraZeneca, vandetanib, thyroid cancer
Roche CEO sees generic co's, innovators as winners
Reuters, UK
Thursday, December 2, 2010 - 4:50pm
tags:
Roche, generics, innovation, Severin Schwan, Pharma CEOs
Is Seattle Genetics the Next Big Thing?
Minyanville
Thursday, December 2, 2010 - 4:47pm
tags:
Seattle Genetics, brentuximab vedotin, lymphoma
Sequenom Falls on Stock Sale
Barron's
Thursday, December 2, 2010 - 4:45pm
tags:
Sequenom, stock offering
GE teams up with J&J on hunt for early Alzheimer's biomarkers
Fierce Biotech
Thursday, December 2, 2010 - 1:00pm
tags:
GE, JNJ, Alzheimer's disease, biomarkers
Cubist says FDA approves fast-injection Cubicin
Yahoo/AP
Thursday, December 2, 2010 - 12:59pm
tags:
FDA, Cubist Pharmaceuticals, Cubicin, antibiotics
Ex-Glaxo lawyer pleads not guilty to obstruction
Reuters
Thursday, December 2, 2010 - 12:15pm
tags:
GSK, antidepressants

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.